Eva M. Gross

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Journal: British journal of cancer

Published: July 12, 2023

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

Journal: Journal of the National Cancer Institute

Published: February 16, 2021

High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.

High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.

Journal: American journal of cancer research

Published: May 03, 2020

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.

Journal: Archives of gynecology and obstetrics

Published: April 09, 2020

Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis.

Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis.

Journal: International journal of molecular sciences

Published: February 19, 2020

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Journal: Human mutation

Published: January 30, 2019

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.

Journal: Breast cancer research : BCR

Published: September 21, 2017

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.

Journal: Cancer medicine

Published: September 19, 2017

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.

Journal: International journal of oncology

Published: June 08, 2017

Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.

Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.

Journal: Oncotarget

Published: April 28, 2017

Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer.

Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer.

Journal: Biological chemistry

Published: March 02, 2017

Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.

Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.

Journal: JAMA oncology

Published: December 30, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026